25 LLC’s BlackRock Health Sciences Trust BME Stock Holding History

25 LLC’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-175	Closed	-$6.96K	–	107
2023 Q2	$6.96K	Hold	175	–	–	﹤0.01%	166
2023 Q1	$7.3K	Buy	+175	New	+$7.36K	﹤0.01%	163

Other funds holding BME

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.06B AUM 12.86% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

25 LLC's BME Position: Q3 2023 in Review

25 LLC sold out of BlackRock Health Sciences Trust (BME) in Q3 2023, closing a stake of 175 shares — an estimated $6.96K sold.

25 LLC first reported a position in BME in Q1 2023 and held it in 2 quarters. The position peaked at $7.3K in Q1 2023. 72 funds tracked by Wall St. Rank hold BME as of Q3 2023.

25 LLC reported no remaining BlackRock Health Sciences Trust position as of Q3 2023 after selling out during the quarter.
25 LLC sold 175 BlackRock Health Sciences Trust shares in Q3 2023, an estimated $6.96K.
25 LLC first reported a position in BlackRock Health Sciences Trust in Q1 2023 and held it in 2 quarters.
25 LLC's BlackRock Health Sciences Trust position peaked at $7.3K in Q1 2023.
72 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.